# Dianthus Therapeutics, Inc.: Form 8-K, filed Jun 30, 2020

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: 8-K
- Filed: 2020-06-30
- Accepted by EDGAR: Jun 30, 2020, 08:14 ET
- Period: 2020-06-24
- Accession: 0001193125-20-183376
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000119312520183376/d854059d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000119312520183376/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000119312520183376/d854059d8k.htm

Filed Jun 30, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-183376. Last ingested by Listed: Nov 10, 2026, 03:21 ET. No prices; not investment advice.